MACCARI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 936
EU - Europa 863
AS - Asia 851
SA - Sud America 84
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 10
Totale 2.804
Nazione #
US - Stati Uniti d'America 902
IT - Italia 296
RU - Federazione Russa 288
CN - Cina 286
SG - Singapore 225
HK - Hong Kong 90
KR - Corea 84
BR - Brasile 68
VN - Vietnam 64
FI - Finlandia 54
DE - Germania 42
FR - Francia 40
NL - Olanda 32
GB - Regno Unito 27
BD - Bangladesh 26
IE - Irlanda 26
CA - Canada 24
SE - Svezia 22
IN - India 19
ID - Indonesia 13
CH - Svizzera 11
AU - Australia 10
JO - Giordania 9
JP - Giappone 9
ZA - Sudafrica 6
AR - Argentina 5
CO - Colombia 5
IQ - Iraq 5
BJ - Benin 4
DZ - Algeria 4
ES - Italia 4
VE - Venezuela 4
AL - Albania 3
CI - Costa d'Avorio 3
ET - Etiopia 3
MX - Messico 3
NG - Nigeria 3
PL - Polonia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
LV - Lettonia 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
TR - Turchia 2
UA - Ucraina 2
AT - Austria 1
BT - Bhutan 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 2.776
Città #
Santa Clara 286
Ashburn 176
Singapore 167
Hefei 107
Seoul 84
Hong Kong 83
San Jose 60
Council Bluffs 45
Milan 41
Florence 38
Beijing 33
Dublin 26
Helsinki 26
Ho Chi Minh City 25
Los Angeles 25
Munich 24
New York 21
Turku 19
Rome 16
Paris 15
Chandler 14
Lauterbourg 14
Jakarta 13
Kent 13
Dallas 12
Hanoi 12
Buffalo 11
Frankfurt am Main 11
Bern 10
London 10
Melbourne 10
The Dalles 10
Lappeenranta 9
Naples 9
Toronto 9
Altamura 8
Lawrence 8
Moscow 8
São Paulo 8
Waltham 8
Amsterdam 7
Tokyo 7
Turin 7
Boston 6
Brooklyn 6
Chicago 6
Shanghai 6
Atlanta 5
Mumbai 5
Brescia 4
Cotonou 4
Haiphong 4
Johannesburg 4
Manchester 4
Modena 4
Orem 4
Princeton 4
Abidjan 3
Abuja 3
Addis Ababa 3
Altopascio 3
Baghdad 3
Chennai 3
Elk Grove Village 3
Genoa 3
Houston 3
Monza 3
Parma 3
Pescara 3
Pisa 3
Porto Alegre 3
San Francisco 3
Tianjin 3
Tirana 3
Warsaw 3
Acquaviva delle Fonti 2
Bari 2
Bengaluru 2
Bexley 2
Bologna 2
Bolzano 2
Boydton 2
Bratislava 2
Bremen 2
Caponago 2
Catania 2
Cesena 2
Charlotte 2
Cipolletti 2
Düsseldorf 2
Empoli 2
Fairfield 2
Falkenstein 2
Figino 2
Greenville 2
Hilversum 2
Jeddah 2
Kolkata 2
Lugo 2
Maranello 2
Totale 1.715
Nome #
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 197
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 194
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 192
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia 191
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 186
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 184
CALR mutation burden in essential thrombocythemia and disease outcome 179
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 179
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience 176
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 161
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML 147
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 143
Increased plasma levels of lncrnas linc01268, gas5 and malat1 correlate with negative prognostic factors in myelofibrosis 143
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 138
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 134
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib 123
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting 117
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications. 20
Totale 2.804
Categoria #
all - tutte 9.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 0 0 0 0 13 0 1 3 6
2022/2023129 9 20 7 10 3 19 21 3 14 7 5 11
2023/2024112 5 7 8 5 18 12 1 21 4 10 10 11
2024/20251.009 18 59 47 132 218 172 50 56 49 38 85 85
2025/20261.443 180 212 191 129 96 45 136 58 101 110 48 137
2026/202788 66 22 0 0 0 0 0 0 0 0 0 0
Totale 2.804